Clinical and radiographic correlation in the use of rhBMP2 for posterolateral lumbar spinal fusion' - PowerPoint PPT Presentation

1 / 21
About This Presentation
Title:

Clinical and radiographic correlation in the use of rhBMP2 for posterolateral lumbar spinal fusion'

Description:

Study Design. Retrospective review of prospectively collected outcomes data. ... Evaluated at Pre-Op, 2-5 weeks, 6 weeks-2 months, 3-5 months, 6-11 months, 1 year. ... – PowerPoint PPT presentation

Number of Views:155
Avg rating:3.0/5.0
Slides: 22
Provided by: www35
Category:

less

Transcript and Presenter's Notes

Title: Clinical and radiographic correlation in the use of rhBMP2 for posterolateral lumbar spinal fusion'


1
Clinical and radiographic correlation in the use
of rhBMP-2 for posterolateral lumbar spinal
fusion.
Nauman Akhtar, MD Department of
Orthopedics Marc Underhill, MD Department of
Radiology Joseph Craig, MD Department of
Radiology Stephen Bartol, MD Department of
Orthopedics
2
Disclosure
  • My disclosure is in the Final Program
  • Book and in the AAOS database.
  • In this study, the participants report no
    conflict of interest, conflict of commitment, or
    financial interest.

3
Objectives
  • Determine the efficacy of rh-BMP2 (bone
    morphogenetic proteins) use in posterior spinal
    fusion surgery.
  • Determine rh-BMP2s ability to influence complete
    fusion rates as determined by radiographic
    analysis.
  • Determine risk factors that lead to
    pseudoarthrosis as determined by radiographic
    analysis.
  • Explore clinical outcomes of patients after
    posterior lumbar fusion enhanced with rh-BMP2.

4
Study Design
  • Retrospective review of prospectively collected
    outcomes data.
  • 83 consecutive patients underwent posterior
    lumbar decompression and fusion
  • All with autograft enhanced with bone
    morphogenetic protein

5
Methods Materials
  • Total of 83 patients were initially evaluated, 63
    were included.
  • All surgeries performed by single senior staff
    orthopaedic surgeon, Dr. Stephen Bartol.
  • All patients underwent lumbar spine posterior
    decompression and fusion between 2003 - 2006.
  • One to Seven levels, all with local autograft
    enhanced with rh-BMP2.
  • Amount of rh-BMP2 utilized per level
  • 1-2 Levels Small Package - 2.8mg
  • 2-4 Levels Medium Package - 5.4mg
  • 5 Levels Large Package - 8.4mg

6
Materials Methods
  • Imaging
  • Primarily AP and Lateral radiographs.
  • Intermixed post operative CT /MRI
  • Images interpreted by one senior staff,
    fellowship trained musculoskeletal radiologist.

7
Materials Methods
  • Clinical Outcome Measures
  • Oswestry Scores
  • Back and Leg Pain Scores
  • Evaluated at Pre-Op, 2-5 weeks, 6 weeks-2 months,
    3-5 months, 6-11 months, 1 year.
  • Comorbidities Evaluated
  • ASA Score
  • Diabetes
  • Smoking
  • BMI

8
Methods Materials
  • Exclusions
  • 20/83- 2 groups
  • 10/83
  • 1 Poor post operative imaging.
  • 5 patients with prior fusion surgery in the
    region in question.
  • 4 patients entirely lost to follow up
  • 10/83
  • Bilateral incomplete fusion, but less than 1 year
    worth of imaging follow up.
  • Expected average fusion rates at HFHS posterior
    fusion rates 12 months

9
Methods Materials
  • Patient Population
  • 23 male patients
  • Age range 34 75, mean 55.4 years of age.
  • 40 female patients
  • Age range 34 84, mean 63 years of age.

10
Methods Materials
  • Radiographic Fusion
  • Determined to be solid if bridging bone with
    confluent trabeculation was evident between the
    transverse processes.

11
Methods Materials
  • Result groups
  • Complete fusion
  • All levels involved with bilateral fusion

12
Methods Materials
  • Result groups
  • Partial fusion
  • All levels fused on a single side.
  • Scattered levels fused on opposite side.

13
Methods Materials
  • Result groups
  • Pseudoarthrosis
  • Bilateral non- fusion
  • At least 1 year post op.

14
Results
15
Results
  • 51 Complete Fusion
  • Average Time to Complete Fusion 306.24 Days
  • Average Time to Fusion of Individual Sides
    283.06 days
  • 16.1 faster than with out rh-BMP2
  • Assuming 1 year expected fusion rate.
  • 2/ 63 patients demonstrated pseudoarthrosis
  • Both patients were smokers, however 54 of our
    total patients were smokers.
  • 2 level fusion, 4 level fusion.

16
Results
  • 2/63 rate of pseudoarthrosis yields a 98.6
    fusion rate.
  • Rates for fusion in other studies with autograft
    alone
  • 83.2, Jorgenson SS et al, Spine 1994
  • 83, Carreon LY et al, Spine 2005
  • 88, Angevine et al, Spine 2007

17
Days to Fusion Per Level
Days to Fusion
Number of Levels
18
Oswestry and VAS Scores
19
Conclusions
  • rhBMP-2 is useful in aiding posterior fusion of
    the spine.
  • As the number of levels increase, the average
    time to fusion also increases.
  • Rate of pseudoarthrosis is significantly
    different with rh-BMP2 than fusion rates with
    autograft alone.
  • Oswestry pain and functional scores seem to
    correlate with radiographic assessment of fusion.
  • Smoking may be a risk factor to pseudoarthrosis,
    however not statistically in this study.

20
References
  • 1.)Bone morphogenetic proteins basic concepts
  • Setti S. Rengachary, M.D.
  • Neurosurg Focus 13(6) Article 2, 2002
  • 2.)A Comparison of Single-Level Fusions With and
    Without Hardware
  • Mark Lorenz, MD, Michael Zindrick, MD, Paul
    Schwaegler, MD, et. Al
  • Department of Orthopaedics and Rehabilitation,
    Loyola Univ. Medical Center
  • Spine Vol 16, Number 8, Supplement 1991
  • 3.)Correlation of Radiologic Assessment of Lumbar
    Spine Fusions with Surgical Exploration.
  • Brodshym MD, Kovalsky, MD, Khalil MD
  • Texas Institute for Spinal Disorders, Houston
    Texas, Baylor Medical College
  • Spine, Volume 16, Number 6, Supplement 1991
  • 4.)Developemental Abnormalities at the
    Lumbosacral Juncture Causing Pain and Disability
  • Hibbs, M.D. F.A.C.S., and Swift MD
  • New York Orthopaedic Dispensary and Hospital,
    New York
  • Surgery, Gynecology, and Obstetrics pages
    604-612
  • 5.)Effect of Regional Gene Therapy with Bone
    Morphogenetic Protein-2-Producing Bone Marrow
    Cells on Spinal Fusion in Rats
  • Wang, MD, Kanim, MA, Yoo, BA, Campbell PhD,
    Berk, MD, Lieberman,MD
  • Department of Orthopaedic Surgery, Univ. of
    California at Los Angles
  • The Journal of Bone and Joint Surgery (American)
    85905-911 (2003)

21
References
  • 6.)Effects of Spinal Instrumentation on Fusion of
    the Lumbosacral Spine
  • Schwab, MD, Nazarian, MD, Mahmud, MD, Michelsen,
    MD
  • Spine Volume 20, Number 18, pp 2023-2028 (1995)
  • 7.)Evaluation of Lumbar Spine Fusion, Plain
    Radiogrpahs Versus Direct Surgical Exploration
    and Observation
  • Kant, MD, Daum, MD, Dean, MD, Uchida, MS
  • Spine Volume 20, Number 21, pp 2313-2317 (1995)
  • 8.)Experimental Spinal Fusion with Use of
    Recombinant Human Bone Morphogenetic Protein 2
  • Itoh, MD, Ebara, MD, Kamimura MD, Tateiwa, MD,
    Kinoshita MD, Yuzawa MD, Takaoka, MD
  • Spine. 24 (14) 1402, July 15, 1999
  • 9.)Lumbar Fusion With and Without Pedicle Screw
    Fixation Comments on a Prospective, Randomized
    Study
  • Angevine, Peter D. MD, MPH Dickman, Curtis MD
    McCormick, Paul MD, MPH
  • Spine 32 (13), 1 June 2007, pp 1466-1471
  • 10) Higher costs with spinal fusion helpers
  • OR Manager, Volume 22 No. 2, February 2006.
Write a Comment
User Comments (0)
About PowerShow.com